BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37793055)

  • 1. Adopting a new approach to treat refractory or resistant viral infections in solid organ transplant recipients.
    Probst V; Thomas SJ; Ouellette CP
    Transpl Infect Dis; 2023 Dec; 25(6):e14161. PubMed ID: 37793055
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous infections from viral sources in solid organ transplant recipients.
    Ilyas M; Maganty N; Sharma A
    J Clin Virol; 2017 Dec; 97():33-37. PubMed ID: 29096391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opportunistic Pulmonary Infections in the Solid Organ Transplant Recipient: A Focus on Drug Therapy.
    Goetz ME; Evans RA; Rendulic T
    Crit Care Nurs Q; 2017; 40(4):399-413. PubMed ID: 28834861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA respiratory viral infections in solid organ transplant recipients.
    Ison MG; Michaels MG;
    Am J Transplant; 2009 Dec; 9 Suppl 4(Suppl 4):S166-72. PubMed ID: 20070677
    [No Abstract]   [Full Text] [Related]  

  • 5. Viral infections in solid organ transplant recipients: novel updates and a review of the classics.
    Haidar G; Singh N
    Curr Opin Infect Dis; 2017 Dec; 30(6):579-588. PubMed ID: 28984642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and Treatment of Cytomegalovirus Infections in Solid Organ Transplant Recipients.
    Koval CE
    Infect Dis Clin North Am; 2018 Sep; 32(3):581-597. PubMed ID: 30146024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus myocarditis in solid organ transplant recipients: A case series and review of literature.
    Scherger S; Mathur S; Bajrovic V; Johnson SC; Benamu E; Ramanan P; Wolfel G; Levi ME; Abidi MZ
    Transpl Infect Dis; 2020 Jun; 22(3):e13282. PubMed ID: 32232951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients.
    Pascual J; Royuela A; Fernández AM; Herrero I; Delgado JF; Solé A; Guirado L; Serrano T; de la Torre-Cisneros J; Moreno A; Cordero E; Gallego R; Lumbreras C; Aguado JM;
    Transpl Infect Dis; 2016 Dec; 18(6):819-831. PubMed ID: 27600985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Update on the management of cytomegalovirus infection in transplant recipients].
    Neofytos D; Van Delden C; Manuel O
    Rev Med Suisse; 2023 Apr; 19(822):726-730. PubMed ID: 37057854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arenaviruses and West Nile Virus in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    Anesi JA; Silveira FP;
    Clin Transplant; 2019 Sep; 33(9):e13576. PubMed ID: 31022306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real world experience with Maribavir for the treatment of cytomegalovirus in solid organ transplant recipients.
    Sabatino DC; Hedvat J; Salerno DM; Pereira MR; Lange NW
    Clin Transplant; 2023 Apr; 37(4):e14929. PubMed ID: 36740886
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice.
    Razonable RR; Humar A
    Clin Transplant; 2019 Sep; 33(9):e13512. PubMed ID: 30817026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 in solid organ transplant recipients: Initial report from the US epicenter.
    Pereira MR; Mohan S; Cohen DJ; Husain SA; Dube GK; Ratner LE; Arcasoy S; Aversa MM; Benvenuto LJ; Dadhania DM; Kapur S; Dove LM; Brown RS; Rosenblatt RE; Samstein B; Uriel N; Farr MA; Satlin M; Small CB; Walsh TJ; Kodiyanplakkal RP; Miko BA; Aaron JG; Tsapepas DS; Emond JC; Verna EC
    Am J Transplant; 2020 Jul; 20(7):1800-1808. PubMed ID: 32330343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey.
    Navarro D; San-Juan R; Manuel O; Giménez E; Fernández-Ruiz M; Hirsch HH; Grossi PA; Aguado JM;
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28859257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral Hepatitis Recommendations for Solid-Organ Transplant Recipients and Donors.
    Faria LC; Terrabuio DRB; Leblebicioglu H; Huprikar S
    Transplantation; 2018 Feb; 102(2S Suppl 2):S66-S71. PubMed ID: 29381580
    [No Abstract]   [Full Text] [Related]  

  • 16. New developments in the management of cytomegalovirus infection after solid organ transplantation.
    Eid AJ; Razonable RR
    Drugs; 2010 May; 70(8):965-81. PubMed ID: 20481654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Infections in Solid Organ Transplant Recipients.
    Mossad SB
    Infect Dis Clin North Am; 2018 Sep; 32(3):xiii-xvii. PubMed ID: 30017490
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors Associated With Genotypic Resistance and Outcome Among Solid Organ Transplant Recipients With Refractory Cytomegalovirus Infection.
    Tamzali Y; Pourcher V; Azoyan L; Ouali N; Barrou B; Conti F; Coutance G; Gay F; Tourret J; Boutolleau D
    Transpl Int; 2023; 36():11295. PubMed ID: 37398559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive Strategies Against Cytomegalovirus and Incidence of α-Herpesvirus Infections in Solid Organ Transplant Recipients: A Nationwide Cohort Study.
    Martin-Gandul C; Stampf S; Héquet D; Mueller NJ; Cusini A; van Delden C; Khanna N; Boggian K; Hirzel C; Soccal P; Hirsch HH; Pascual M; Meylan P; Manuel O;
    Am J Transplant; 2017 Jul; 17(7):1813-1822. PubMed ID: 28039960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe infections in critically ill solid organ transplant recipients.
    Kalil AC; Sandkovsky U; Florescu DF
    Clin Microbiol Infect; 2018 Dec; 24(12):1257-1263. PubMed ID: 29715551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.